Product Images Donepezil Hydrochloride

This is a description of a medication that contains Dorl hydrochloride and Donepezil Hydrochloride in tablet form. The tablets are coated and must be stored in a controlled room temperature between 59°F to 86°F (15°C to 30°C). They should be dispensed in tight containers and the packaging includes dosage and usage instructions. The manufacturer is CADILA PHARMACEUTICALS LTD in India.*

Each film-coated tablet contains 10 mg of Donepezil Hydrochloride USP. This medication is prescribed to treat dementia related to Alzheimer's disease. The tablets should be stored at temperatures between 15°C and 30°C. The medication should be dispensed in tight containers that conform to the USP standards. It is manufactured by Cadila Pharmaceuticals Ltd. in India.*

This is a medication description for Donepezil Hydrochloride Tablets USP, manufactured by Cadila Pharmaceuticals Ltd. The tablets are coated and each tablet contains 5 mg of Donepezil Hydrochloride USP. The dosage and usage information must be obtained from the prescribing information. The tablets should be stored in tight containers at room temperature between 59°F to 86°F. The product is only available on prescription and comes in a pack of 1000 tablets. The National Drug Code (NDC) for this product is 71209-019-11.*

Each tablet of Donepezil hydrochloride USP 5mg is film-coated and has the NDC number 71209-019-01. The recommended dosage and instructions for use can be found in the accompanying prescribing information. The tablets should be stored at a controlled room temperature between 59° to 86°F (15° to 30°C). They should only be dispensed in USP containers. The manufacturer is CADILA PHARMACEUTICALS LTD. located in Bhid 1389, Dhlka, Dist, Ahmedabid, Gujarat, DA.*

Each film-coated tablet of Donepezi Hydrochloride USP 5mg contains NG71203-019-04. It is a prescription medication used for treatment and should be used as per the prescribing information. Store in a cool and dry place between 15 to 30 degree Celsius, in a tight container, and out of reach of children. Manufactured by Cadila Pharmaceuticals Ltd. in India.*

This is a table that displays information about Donepezil Hydrochloride Tablets dosage of 10 mg/day and 5 mg/day. There is also an option for Placebo. The table also includes a rating scale from Markedly Improved to Worse using CIBIC plus Rating.*

This appears to be a chart or graph showing the percentage of patients who experienced different levels of improvement after taking either Donepezil Hydrochloride tablets at 10mg/day or 5mg/day. The chart shows different levels of improvement, ranging from markedly improved to markedly worse, as well as the percentage of patients who experienced each level of improvement. There is also a CIBIC-plus rating included.*

This is a table representing the SIB (Severe Impairment Battery) change from baseline for three different treatments: Donepezil Hydrochloride, Placebo, and Tablets 10 mg/day. The table shows numerical values for each treatment option, but there is no additional information available to provide context or further explanation.*

This is a data table showing the percentage of patients who experienced improvement or worsened based on their CIBIC-plus rating when taking Donepezil Hydrochloride tablets in varying dosages. Information on the dosages administered is also provided.*